JPWO2023049852A5 - - Google Patents
Info
- Publication number
- JPWO2023049852A5 JPWO2023049852A5 JP2024518570A JP2024518570A JPWO2023049852A5 JP WO2023049852 A5 JPWO2023049852 A5 JP WO2023049852A5 JP 2024518570 A JP2024518570 A JP 2024518570A JP 2024518570 A JP2024518570 A JP 2024518570A JP WO2023049852 A5 JPWO2023049852 A5 JP WO2023049852A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- polypeptide
- acid sequence
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163261561P | 2021-09-23 | 2021-09-23 | |
| US63/261,561 | 2021-09-23 | ||
| PCT/US2022/076951 WO2023049852A1 (en) | 2021-09-23 | 2022-09-23 | Adenoviruses and methods for using adenoviruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024536835A JP2024536835A (ja) | 2024-10-08 |
| JPWO2023049852A5 true JPWO2023049852A5 (https=) | 2025-10-02 |
| JP2024536835A5 JP2024536835A5 (https=) | 2025-10-02 |
Family
ID=85721290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518570A Pending JP2024536835A (ja) | 2021-09-23 | 2022-09-23 | アデノウイルス及びアデノウイルスの使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240398939A1 (https=) |
| EP (1) | EP4404947A4 (https=) |
| JP (1) | JP2024536835A (https=) |
| CN (1) | CN118354779A (https=) |
| AU (1) | AU2022349649A1 (https=) |
| CA (1) | CA3233100A1 (https=) |
| WO (1) | WO2023049852A1 (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2487811A1 (en) | 2002-05-27 | 2003-12-04 | Per Sonne Holm | Use of adenoviruses replicating in a yb-1 dependent manner for the treatment of tumors |
| US20080063656A1 (en) * | 2004-08-09 | 2008-03-13 | Emini Emilio A | Adenoviral Vector Compositions |
| US8926987B2 (en) | 2004-11-18 | 2015-01-06 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Replication-competent adenoviral vectors |
| WO2011022002A1 (en) * | 2009-08-18 | 2011-02-24 | The Rockefeller University | Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| US20120283318A1 (en) | 2009-10-05 | 2012-11-08 | Mei Ya-Fang | Replicating viral vectors for gene therapy |
| WO2012088041A1 (en) * | 2010-12-20 | 2012-06-28 | Genvec, Inc. | Adenoviral vector-based dengue fever vaccine |
| WO2014093270A1 (en) | 2012-12-10 | 2014-06-19 | Virginia Commonwealth University | Tropism modified cancer terminator virus (ad.5/3 ctv;ad.5/3-ctv-m7) |
| AU2014338864C1 (en) | 2013-10-25 | 2020-07-16 | Akamis Bio Limited | Oncolytic adenoviruses armed with heterologous genes |
| PE20180241A1 (es) | 2015-04-30 | 2018-01-31 | Psioxus Therapeutics Ltd | Adenovirus oncolitico que codifica una proteina b7 |
| US11866724B2 (en) * | 2016-04-06 | 2024-01-09 | Gene Bridges Gmbh | Adenoviral vectors |
| EP3565578A1 (en) | 2016-12-21 | 2019-11-13 | Memgen LLC | Armed replication-competent oncolytic adenoviruses |
| GB201804473D0 (en) | 2018-03-21 | 2018-05-02 | Valo Therapeutics Oy | Modified oncolytic adenoviruses |
| CA3120715A1 (en) * | 2018-11-21 | 2020-05-28 | Mayo Foundation For Medical Education And Research | Adenoviruses and methods for using adenoviruses |
-
2022
- 2022-09-23 EP EP22873891.0A patent/EP4404947A4/en active Pending
- 2022-09-23 JP JP2024518570A patent/JP2024536835A/ja active Pending
- 2022-09-23 AU AU2022349649A patent/AU2022349649A1/en active Pending
- 2022-09-23 WO PCT/US2022/076951 patent/WO2023049852A1/en not_active Ceased
- 2022-09-23 CN CN202280077528.1A patent/CN118354779A/zh active Pending
- 2022-09-23 CA CA3233100A patent/CA3233100A1/en active Pending
- 2022-09-23 US US18/694,830 patent/US20240398939A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1227360C (zh) | Mage家族肿瘤相关抗原衍生物及其编码核酸序列 | |
| JP4799789B2 (ja) | ヒト細胞中での発現用に最適化された合成ヒトパピローマウイルス遺伝子 | |
| US7001995B1 (en) | Synthetic human papillomavirus genes | |
| CN1252840A (zh) | 甲胎蛋白表达细胞的腺病毒载体及其使用方法 | |
| CN1314948A (zh) | 用于递送异源基因的定向腺病毒载体 | |
| JP5148116B2 (ja) | 癌胎児性抗原融合タンパク質及びその使用 | |
| CA3159913A1 (en) | Viruses with modified capsid proteins | |
| JP2001505047A (ja) | 高キャパシティーアデノウイルスベクターの開発の促進に使用するためのパッケージング細胞系 | |
| JP2002511751A (ja) | スプライシング配列を含んでなる組換えアデノウイルスベクター | |
| JPWO2021102107A5 (https=) | ||
| CN100471957C (zh) | 用于免疫治疗的腺病毒载体 | |
| US20070104685A1 (en) | Synthetic gene encoding human carcinoembryonic antigen and uses thereof | |
| CN1656116A (zh) | 包含hpv－16病毒的突变e7蛋白的非免疫抑制免疫原性组合物或疫苗组合物 | |
| JP7229151B2 (ja) | Ｈｐｖワクチン | |
| JPWO2023049852A5 (https=) | ||
| US20060286114A1 (en) | Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof | |
| EP1597370B1 (en) | Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof | |
| JP2024536835A (ja) | アデノウイルス及びアデノウイルスの使用方法 | |
| CN1248733C (zh) | Tie2受体介异的靶向性肿瘤基因治疗的基因转移系统 | |
| CN1420169A (zh) | 多功能抗癌重组腺病毒及其在治疗预防肿瘤上的应用 | |
| NZ783284B2 (en) | Modified adenoviruses | |
| NZ783284A (en) | Modified adenoviruses | |
| CN1634595A (zh) | Tie2受体介导的靶向性肿瘤基因治疗的基因转移系统 | |
| Property | Patent reports | |
| ZA200508013B (en) | Synthetic gene encoding human carcinoembryonic antigen and use thereof |